Beam Therapeutics BEAM EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's EPS (basic)?
- Beam Therapeutics (BEAM) reported EPS (basic) of -$0.91 in Q1 2026.
- How has Beam Therapeutics's EPS (basic) changed year-over-year?
- Beam Therapeutics's EPS (basic) increased by 26.0% year-over-year, from -$1.23 to -$0.91.
- What is the long-term trend for Beam Therapeutics's EPS (basic)?
- Over 2 years (2021 to 2024), Beam Therapeutics's EPS (basic) has grown at a -12.0% compound annual growth rate (CAGR), from -$5.91 to -$4.58.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.